Transform care delivery
To keep pace with the growing diabetic population, healthcare providers need a testing solution that’s fast, flexible, and reliable. Building upon one of the industry’s most trusted technologies for diabetes testing, the Atellica DCA Analyzer can help your care network thrive. Delivering an actionable HbA1c result in minutes allows your clinicians to have meaningful discussions with patients during their visit.
Industry-leading immunoassay technology delivers reliable performance and excellent precision across the entire assay range, ensuring confidence test after test. Expand your diabetes management program to better serve your clinical staff and patients with the Atellica DCA Analyzer solution.
Meet the needs of an expanding patient population
The Atellica DCA Analyzer is designed to accommodate an increase in testing volume. Up to 3 Atellica DCA modules can be connected and run independently for simultaneous testing. Run multiple patients’ tests at the same time, or a single patient’s HbA1c and ACR. Customize and optimize your workflow based on your specific needs and scale up or down accordingly.
POC diabetes testing that correlates with the lab
The Atellica DCA Analyzer is NGSP and IFCC Certified. You can feel confident with lab-quality2 results at the point of care.
Lab-quality results using technology with 30+ years of proven clinical reliability.
- Atellica DCA Analyzer strongly correlated to results from the Tosoh G8 laboratory method.3
- No clinically significant interferences from common hemoglobin variants for HbA1c measurements.4
- Atellica DCA HbA1c test is not affected by hemolyzed samples and can help reduce preanalytical errors.
Simplify your workflows and improve patient experience
Offering accurate results in minutes, from anywhere in the testing environment, the Atellica DCA Analyzer is designed to make diabetes testing fast and efficient for patients, providers, and organizations. Small sample size, rapid results, and the ability to process hemolyzed samples mitigate pre-analytical errors and reduce patient discomfort from re-sticks. Built-in patient trend graphs complement patient consultations and aid in clinical decision making to help your patients have a better visit experience.
Small sample size (1 µL) reduces patient discomfort and reduces risk of insufficient sample
HbA1c results available in minutes, ensuring timely patient consultation and treatment path
Patient trend graphs enable immediate review of results to help reinforce treatment plans
Not affected by hemolyzed samples and can help reduce preanalytical errors